A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma
Clinical trial NCT01987492 · COMPLETED
Trial details
- NCT number
- NCT01987492
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-28
- Primary completion
- 2016-12-20
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.